Pfizer, an American-based pharmaceutical company has developed a vaccine for COVID-19. Several governments worldwide, including Australia, have approached Pfizer with the prospect of manufacturing the vaccine in their respective countries. As a member of Pfizer's supply chain team, you are asked for your views.

What are the risks associated with expanding manufacturing to new global locations? (5 marks)

What are the potential risks of outsourcing manufacturing operations to a third party, for example, allowing organizations such as CSL (an Australian pharmaceutical company) to manufacture the vaccine under license in Australia? (5 marks)

Could you please provide about 200 words for each question ( each question worth 5 marks)with examples to support your idea?